|
Our pharmaceutical development center is dedicated to finding the most rapid and cost-effective route to move molecule from development to commercialization products, also prepares regulatory documentation, develops and scale production technologies, develops and validates the methods of product quality control.
On June 4th 2008 the opening ceremony for R&D center "Max-Well" was held in Borispol; Carlos Gutierrez, US Secretary of Commerce, William Taylor, US extraordinary and plenipotentiary ambassador to Ukraine, Alexandre Fyodorovich Vozianov, President of the Academy of Medical Sciences of Ukraine were present at the ceremony.
Highly qualified personnel of R&D center and the laboratories equipment make it possible to develop and commercial manufacturing application a wide range of dosage forms, including lyophilized powders, suppositories, etc.
Our success depends on high quality of new products. To this effect, we have established the innovative pharmaceutical development center with unique for Ukraine equipment. For instance, titrator with the photometer "Metrohm" makes it possible to apply high-precision analytical techniques. The device for measurement of dissolution kinetics of solid and semi-solid particles "Sotax" enables the development of dosage forms, which fully meet the current WHO regulations. Using "Camage", the instrument to record thin-layer chromatography results, physical and chemical purity of substances, test samples and finished products are under precise control.
Pharmaceutical development center of SOCPC "Max-Well" is certified by the Ukrainian State Research-and-Production Center of Standardization, Metrology, Certification and Protection of Consumers.
Fully integrated and seamless approach to pharmaceutical development with the highest quality is one of the bases for high quality of "Max-Well" products.
|
